New Mathematical Model Improves Prediction of Mitochondrial Disease Risk
Researchers have proposed a new stochastic mathematical framework using complex numbers to model mitochondrial heteroplasmy — the coexistence of normal and mutant mitochondrial DNA within cells. The model integrates selection, genetic drift, and inter-tissue migration of mitochondrial genomes, using Monte Carlo simulations to assess disease risk across tissue types. The approach could enable more personalized risk prediction for mitochondrial diseases, which are notoriously difficult to forecast due to threshold effects and tissue-specific variability.
A preprint posted to bioRxiv introduces a complex-phase stochastic model designed to better capture the dynamics of mitochondrial heteroplasmy, a condition in which cells carry both wild-type and mutant copies of mitochondrial DNA (mtDNA). Traditional models rely on a simple scalar fraction of mutant DNA, which the authors argue fails to account for stochastic variability, threshold effects, and differences between tissue types. The new formalism represents each cell's mitochondrial state as a complex number, where the two components encode the absolute counts of normal and mutant mtDNA, and the phase angle reflects mutant load. Running 1,000 Monte Carlo simulations, the researchers found that neuronal tissues exhibit particularly high heteroplasmy variability and a meaningful probability of crossing pathological thresholds even when the overall systemic mutant load is relatively low. Kaplan-Meier survival analysis was applied to frame disease onset as a probabilistic time-to-event process. The authors contend the model opens pathways toward individualized prognosis for patients with mitochondrial diseases. The work is currently a preprint and has not yet undergone peer review.
What's missing
As a preprint, this work has not been peer-reviewed. Key limitations and open questions include: whether the model's parameters (selection coefficients, migration rates, drift magnitudes) are empirically validated against patient data; how the complex-phase formalism performs compared to existing stochastic models (e.g., Wright-Fisher or Moran models for heteroplasmy); and whether the tissue-specific findings for neurons have been tested against clinical or experimental datasets. The study does not appear to address how the model would handle de novo mutation rates or the role of mitophagy in heteroplasmy dynamics.
What different sources said
- bioRxivCenter
Complex-phase stochastic modeling of mitochondrial heteroplasmy
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.